ENDITIMEX
100MG CPS DUR 10
SÚKL code | 0220643 |
---|---|
Name of the product | ENDITIMEX |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | ENDITIMEX |
Supplement | 100MG CPS DUR 10 |
Strenght | 100MG |
Pharmaceutical form | Capsule, hard |
Package | 10 |
Route | Oral use |
Language of the pack | Czech |
Wrap type | Blister |
Legal status | OTC medicinal products |
Active substance | RACECADOTRIL (RACECADOTRILUM) |
ATC group | A07XA04 |
ATC group name | RACEKADOTRIL |
Marketing authorisation information
Registration Number | 49/1018/16-C |
---|---|
Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 30. 09. 2020 |
MA Holder | sanofi-aventis, s.r.o., Praha |
MA Holder country | ČESKÁ REPUBLIKA |
Actual MA holder | Opella Healthcare Czech s.r.o., Praha |
Actual MA holder country | ČESKÁ REPUBLIKA |